Davis Todd C bought LGND
February 27, 2024 · Form 4 insider transaction
Davis Todd C bought 131,723 shares of Ligand Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
131,723
Price
$0.00
Total value
N/A
InsiderDavis Todd C
Role—
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2024
Filing dateFebruary 29, 2024
Shares owned after131,723
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.